Go back

Pharma spend on neglected disease research blooms

Image: Center for Disease Control and Prevention, via Wikimedia Commons

Industry investment reached almost US$600m in 2018, highlighting growth in clinical R&D

The pharmaceutical industry is the second-biggest investor globally in neglected tropical disease R&D, beating the Bill & Melinda Gates Foundation for the second year running, fresh data reveals.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.